Hayward, CA, United States of America

Benitec Biopharma Limited


USPTO Granted Patents = 8

% Expired Patents = 75.0


Forward Citations = 12

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Michael Wayne Graham (4 out of 15 patents)

silverMedal Peter French (4 out of 4 patents)

bronzeMedal David A Suhy (4 out of 14 patents)

4.  York YuanYuan Zhu (3 out of 5 patents)

5.  YiXiang Lu (3 out of 5 patents)

6.  YunCheng Sun (3 out of 5 patents)

7.  Li Shan (3 out of 3 patents)

8.  XiaoJun Tang (3 out of 3 patents)

9.  Michael Graham (2 out of 2 patents)

10.  Tin Mao (2 out of 3 patents)

11.  Shih-Chu Kao (2 out of 2 patents)

12.  TieJun Li (2 out of 2 patents)

13.  Capucine Trollet (1 out of 1 patent)

14.  Alberto Malerba (1 out of 1 patent)

15.  Mark A Kay (1 out of 58 patents)


8 patents:

Company Overview
Benitec Biopharma Limited is a biotechnology company focused on developing novel genetic medicines. They utilize their proprietary gene-silencing technology to target and treat a variety of diseases including hepatitis C, oculopharyngeal muscular dystrophy, and cancer. With a strong pipeline of therapeutic candidates, Benitec aims to revolutionize the treatment of genetic disorders and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#72 in Hayward, CA

#8,531 in California

#35,893 in US

Hayward, CA (US)
Hayward, CA, United States of America
Forward Citations = 12

19 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Benitec Biopharma Limited. Retrieved from https://idiyas.com/company/benitec-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…